Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL-28 | 0.03MG;0.15MG | 0 | ALTAVERA | ETHINYL ESTRADIOL; LEVONORGESTREL |
FDA Submissions
| ORIG | 1 | AP | 2010-08-03 | |
LABELING; Labeling | SUPPL | 2 | AP | 2011-05-24 | |
LABELING; Labeling | SUPPL | 6 | AP | 2014-02-25 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2017-08-09 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2020-03-03 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2022-03-04 | STANDARD |
LABELING; Labeling | SUPPL | 12 | AP | 2022-04-29 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 7 |
SUPPL | 6 | Null | 15 |
SUPPL | 8 | Null | 15 |
SUPPL | 9 | Null | 7 |
SUPPL | 10 | Null | 7 |
SUPPL | 12 | Null | 7 |
TE Codes
CDER Filings
XIROMED
cder:Array
(
[0] => Array
(
[ApplNo] => 79102
[companyName] => XIROMED
[docInserts] => ["",""]
[products] => [{"drugName":"ALTAVERA","activeIngredients":"ETHINYL ESTRADIOL; LEVONORGESTREL","strength":"0.03MG;0.15MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ALTAVERA","submission":"ETHINYL ESTRADIOL; LEVONORGESTREL","actionType":"0.03MG;0.15MG","submissionClassification":"TABLET;ORAL-28","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)